Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Smith & Nephew Snats ( (SNN) ) is now available.
On March 11, 2025, Smith & Nephew plc announced the vesting of share awards under its Global Share Plan 2020. The vesting included the 2022 Performance Share Programme and the final vesting of 2022 Deferred Bonus Share Awards, with shares sold to cover tax obligations. The vesting impacts key managerial personnel, reflecting the company’s commitment to rewarding its leadership and aligning their interests with shareholders.
More about Smith & Nephew Snats
Smith & Nephew plc is a global medical technology company headquartered in Watford, England. The company specializes in advanced wound management, orthopaedics, and sports medicine, focusing on providing innovative solutions for healthcare professionals and patients worldwide.
YTD Price Performance: 21.89%
Average Trading Volume: 800,701
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $13.06B
For detailed information about SNN stock, go to TipRanks’ Stock Analysis page.

